Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Moxilubant is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 26,000 |
5 mg | お問い合わせ | ¥ 60,000 |
10 mg | お問い合わせ | ¥ 89,500 |
25 mg | お問い合わせ | ¥ 174,000 |
50 mg | お問い合わせ | ¥ 236,500 |
100 mg | お問い合わせ | ¥ 365,000 |
500 mg | お問い合わせ | ¥ 803,000 |
説明 | Moxilubant is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis. |
In vitro | Moxilubant inhibits LTB4 signaling with a potency of 2–4 nM.[1] |
In vivo | Moxilubant (100 to 500 mg; oral; once or twice daily for 7 days) inhibition LTB4 pathway reached at least 75% (150 mg) and pathway inhibition reached 100% (300 mg).[1] |
分子量 | 455.59 |
分子式 | C26H37N3O4 |
CAS No. | 146978-48-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Moxilubant 146978-48-5 Immunology/Inflammation LTR Inhibitor inhibitor inhibit